FilingSEC EDGAR6-K
Ping An Biomedical Evaluating Reverse Stock Split to Regain Nasdaq Compliance
· SEC accepted
StageUnder Evaluation
Filing content
Ping An Biomedical is evaluating options, including a reverse stock split, to regain compliance with Nasdaq's minimum bid price requirement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…